Quantum BioPharma grants 7,692 stock options to director Zapolin at C$ 6.6 per share
QNTM•Options granted to director and warrants cancelled
Quantum BioPharma cancelled 7,692 warrants held by director Michael (Zappy) Zapolin to buy Class B subordinate voting shares.
The company granted Zapolin 7,692 stock options under its equity incentive plan, exercisable at C$6.6 per Class B share.
The options expire March 7, 2027.
